Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Xinyi Pharmaceutical Co., Ltd. is a prominent pharmaceutical manufacturer based in Dezhou, Shandong Province, and operates as a key subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH). The company focuses on the development and production of high-quality chemical drug formulations and active pharmaceutical ingredients (APIs) across several therapeutic areas, including endocrinology, cardiovascular disease, and gastroenterology. It is particularly recognized for its large-scale production of essential medicines such as metformin hydrochloride, which has passed the national consistency evaluation for generic drugs. Shandong Xinyi maintains advanced manufacturing facilities that adhere to strict Good Manufacturing Practice (GMP) standards to ensure product safety and efficacy. By leveraging the research and distribution network of its parent company, SPH, Shandong Xinyi serves as a vital link in the Chinese pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Xinyi Pharmaceutical.